Search

Your search keyword '"Prota, G."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Prota, G." Remove constraint Author: "Prota, G." Topic humans Remove constraint Topic: humans
34 results on '"Prota, G."'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

3. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

4. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

5. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

6. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

7. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

8. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

9. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

10. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

11. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

12. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

13. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

14. Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV‐infected patients with virological suppression

15. Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort

16. Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV

17. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting

18. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study

19. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure

20. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

21. Variously Substituted (Phosphonoacetamido)Oxy Analogues of Geranylgeranyl Diphosphate (GGdP) as GGdP-transferase (GGTase) Inhibitors and Antiproliferative Agents

22. Development of an integrated method of skin phenotype measurement using the melanins

23. Melanin pigmentation in mammals

25. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus

26. Synthesis and cytotoxic properties of new N-substituted 4-aminophenol derivatives with a potential as antimelanoma agents

27. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus

28. Skin Depigmentation by Hydroquinone: A Chemical and Biochemical Insight

29. Metabolically labile cannabinoid esters: a 'soft drug' approach for the development of cannabinoid-based therapeutic drugs

30. Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson's disease: a critical update

31. Iron-Mediated Generation of the Neurotoxin 6-Hydroxydopamine Quinone by Reaction of Fatty Acid Hydroperoxides with Dopamine: A Possible Contributory Mechanism for Neuronal Degeneration in Parkinson's Disease

32. Melanogenesis as a targeting strategy against metastatic melanoma: A reassessment

33. An unusual case of trimethylaminuria

34. Identification of cysteinyldopa-derived units in eumelanins from mammalian eyes

Catalog

Books, media, physical & digital resources